ICOSLG and neoplasm: The crosslinking of ICOS and ICOSL has stimulating activities, promoting an anti-tumor response by Th1, CTL and T follicular helper (Tfh) and a pro-tumor response mediated by Tregs and Th2 cells in the tumor microenvironment.